NASDAQ: BBOT

BridgeBio Oncology Therapeutics Inc.

Healthcare | Biotechnology

No licensed closing price on file for BBOT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

BridgeBio Oncology Therapeutics Inc. (NASDAQ: BBOT) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:08 UTC.

Key facts

Charts

Charts are in the appInteractive charts for BBOT are available in Oxford Ledge.
Open BBOT in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-10-05

2026-10-05Principal Accounting OfficerTax withholding-126$496
2026-10-05COO & Principal Financial OfcrTax withholding-343$1.4K
2026-10-05President and CEOTax withholding-1,047$4.1K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Cormorant Asset Management, LP17,878,594$136.23M0.0%
DEERFIELD MANAGEMENT COMPANY, L.P.4,885,446$37.23M0.0%
Omega Fund Management, LLC3,289,661$25.07M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-04-29Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-02-14Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersJohn SchmidAuthoritativeSEC 8-K →

Company news

View all →

No qualifying company news in the archive. Full tape in the platform →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BBOT and 5,000+ tickers.

Create a free account — keep BBOT

For your agent

GET /api/data?ticker=BBOT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt